Cargando…
Development of Eczema Vaccinatum in Atopic Mouse Models and Efficacy of MVA Vaccination against Lethal Poxviral Infection
Smallpox vaccine based on live, replicating vaccinia virus (VACV) is associated with several potentially serious and deadly complications. Consequently, a new generation of vaccine based on non-replicating Modified vaccinia virus Ankara (MVA) has been under clinical development. MVA seems to induce...
Autores principales: | Knitlova, Jarmila, Hajkova, Vera, Voska, Ludek, Elsterova, Jana, Obrova, Barbora, Melkova, Zora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259321/ https://www.ncbi.nlm.nih.gov/pubmed/25486419 http://dx.doi.org/10.1371/journal.pone.0114374 |
Ejemplares similares
-
Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism
por: Pilna, Hana, et al.
Publicado: (2021) -
Vaccinia immune globulin ameliorates eczema vaccinatum in a murine model of atopic dermatitis
por: Oyoshi, Michiko K., et al.
Publicado: (2011) -
Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice
por: Langenmayer, Martin C., et al.
Publicado: (2023) -
Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum
por: Kawakami, Yuko, et al.
Publicado: (2009) -
Expression and Cellular Immunogenicity of a Transgenic Antigen Driven by Endogenous Poxviral Early Promoters at Their Authentic Loci in MVA
por: Orubu, Toritse, et al.
Publicado: (2012)